MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6
|
disease |
|
Disease or Syndrome
|
1
|
2
|
0.600 |
None |
1.000 |
1 |
2
|
2013 |
2013 |
Episodic ketoacidosis
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
10
|
1
|
0.300 |
None |
|
0 |
|
|
|
Comedone
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
53
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adult Anaplastic Astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
90
|
8
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Grade III Childhood Astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
90
|
8
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hyperammonemia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
102
|
8
|
0.100 |
None |
|
0 |
|
|
|
Optic Atrophy 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
117
|
45
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Ketosis
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
119
|
11
|
0.010 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Increased serum lactate
|
phenotype |
Nutritional and Metabolic Diseases
|
Finding
|
169
|
2
|
0.100 |
None |
|
0 |
|
|
|
Anaplastic astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
202
|
12
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Acidosis, Lactic
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
209
|
21
|
0.100 |
None |
|
0 |
|
|
|
Elevated hepatic transaminase
|
phenotype |
|
Finding
|
212
|
9
|
0.100 |
None |
|
0 |
|
|
|
Liver Failure, Acute
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
282
|
21
|
0.100 |
None |
|
0 |
|
|
|
Meningioma, benign, no ICD-O subtype
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
404
|
30
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adult Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
405
|
30
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Encephalopathies
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
457
|
64
|
0.100 |
None |
|
0 |
|
|
|
Noninfiltrating Intraductal Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
486
|
13
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mental deterioration
|
phenotype |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
508
|
121
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
634
|
43
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malaria
|
disease |
Infections
|
Disease or Syndrome
|
685
|
148
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Hyperglycemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1098
|
108
|
0.010 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Impaired cognition
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1630
|
348
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |